Natixis Advisors, L.P. Becton Dickinson & CO Transaction History
Natixis Advisors, L.P.
- $63 Billion
- Q2 2025
A detailed history of Natixis Advisors, L.P. transactions in Becton Dickinson & CO stock. As of the latest transaction made, Natixis Advisors, L.P. holds 170,683 shares of BDX stock, worth $32.9 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
170,683
Previous 436,600
60.91%
Holding current value
$32.9 Million
Previous $100 Million
70.6%
% of portfolio
0.05%
Previous 0.18%
Shares
32 transactions
Others Institutions Holding BDX
# of Institutions
1,739Shares Held
260MCall Options Held
1.82MPut Options Held
696K-
Vanguard Group Inc Valley Forge, PA32.3MShares$6.22 Billion0.09% of portfolio
-
Black Rock Inc. New York, NY22.3MShares$4.29 Billion0.12% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD16.2MShares$3.11 Billion1.76% of portfolio
-
State Street Corp Boston, MA13.4MShares$2.58 Billion0.09% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD8.88MShares$1.71 Billion0.17% of portfolio
About BECTON DICKINSON & CO
- Ticker BDX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 285,195,008
- Market Cap $54.9B
- Description
- Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...